R

Regenxbio

Rockville, United States Founded 2009 NASDAQ: RGNX

About

AAV gene therapy using NAV Technology Platform

Company Details

Type
public
Employees
500+
Funding
Public

Key Products

  • NAV Vectors
  • Gene Therapy
Visit Website

Related Companies